AZZ Inc. provides hot-dip galvanizing and coil coating solutions in North America. It offers metal finishing solutions for corrosion protection, including hot-dip galvanizing, spin galvanizing, powder coating, anodizing, and plating to steel fabrication and other industries, as well as to fabricators or manufacturers that provide services to the transmission and distribution, bridge and highway, petrochemical, and general industrial markets; and original equipment manufacturers. It also provides aesthetic and corrosion protective coatings and related value-added services for steel and aluminum coil primarily serving the construction; appliance; heating, ventilation, and air conditioning; container; transportation; and other end markets. The company was incorporated in 1956 and is headquartered in Fort Worth, Texas.

AZZ Inc.

Analysts have been eager to weigh in on the Healthcare sector with new ratings on CVRx (CVRX), Jazz Pharmaceuticals (JAZZ) and Disc Medicine (IRON)...

Analysts Conflicted on These Healthcare Names: CVRx (CVRX), Jazz Pharmaceuticals (JAZZ) and Disc Medicine (IRON)

Morgan Stanley analyst Sean Laaman maintained a Buy rating on Jazz Pharmaceuticals yesterday and set a price target of $283.00. The company’s share...

Morgan Stanley Reaffirms Their Buy Rating on Jazz Pharmaceuticals (JAZZ)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Jazz Pharmaceuticals (JAZZ), Surgery Partners (SGRY)...

Analysts Are Bullish on Top Healthcare Stocks: Jazz Pharmaceuticals (JAZZ), Surgery Partners (SGRY)

The latest announcement is out from Jazz Pharmaceuticals ( ($JAZZ) ). On August 10, 2026, Jazz Pharmaceuticals agreed to acquire privately held Act...

Jazz Pharmaceuticals to Acquire Rare Epilepsy Specialist Actio

Wells Fargo analyst Mohit Bansal assigned a Buy rating to Jazz Pharmaceuticals yesterday and set a price target of $300.00. Bansal covers the Healt...

Jazz Pharmaceuticals (JAZZ) Receives a Buy from Wells Fargo

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on HealthStream (HSTM) and Jazz Pharmaceuticals (JAZZ) ...

Analysts Offer Insights on Healthcare Companies: HealthStream (HSTM) and Jazz Pharmaceuticals (JAZZ)

AZZ ( ($AZZ) ) has issued an announcement. On August 3, 2026, AZZ Inc. appointed veteran human resources executive Rhonda Davenport as Chief Human ...

AZZ Appoints Rhonda Davenport as Chief HR Officer

There’s a lot to be optimistic about in the Industrial Goods sector as 3 analysts just weighed in on CNH Industrial (CNH), SPX (SPXC) and AZZ (AZZ)...

Wall Street Analysts Are Bullish on Top Industrial Goods Picks

Jazz Pharmaceuticals ($JAZZ) announced an update on their ongoing clinical study. Jazz Eyes Adult LGS Opportunity With New CBD Study. Jazz Pharmace...

Jazz Pharmaceuticals Targets Adult LGS Growth With New Cannabidiol Dosing Study

Jazz Pharmaceuticals ( ($JAZZ) ) has issued an update. At its July 23, 2026 annual general meeting in Dublin, Jazz Pharmaceuticals’ shareholders el...

Jazz Pharmaceuticals Shareholders Reaffirm Board and Governance Plans

Goldman Sachs analyst maintained a Buy rating on Azzas 2154 SA today and set a price target of BRL30.00. Azzas 2154 SA has an analyst consensus of ...

Goldman Sachs Remains a Buy on Azzas 2154 SA (AZZA3)

Jazz Pharmaceuticals ($JAZZ) announced an update on their ongoing clinical study. Jazz Pharmaceuticals is running a Phase 2 study called “A Phase 2...

Jazz Targets Lung Cancer Growth With New Lurbinectedin–Durvalumab Trial

Analysts are intrested in these 5 stocks: ( ($JAZZ) ), ( ($AAPL) ), ( ($AEP) ), ( ($MCO) ) and ( ($MMM) ). Here is a breakdown of their recent


	A	B	C	D
1	Symbol	Price	Change	Volume
2	AZZ	$151.35	0.00%	222.43K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	AZZ	$151.35	0%	222.43K
3
4
5
6

AZZ

Get AZZ Inc. Data in Excel

Get AZZ Inc. Data in Excel